SALIOGEN
DEAD

Serial Number

90517623

Owner

Saliogen Therapeutics, Inc.

Attorney

Rachelle A. Dubow, Esq.

Filing Date

Feb 8, 2021

Add to watchlist:

No watchlists yet
View on USPTO

SALIOGEN Trademark

Serial Number: 90517623

SALIOGEN is a trademark filed by Saliogen Therapeutics, Inc. on February 8, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Saliogen Therapeutics, Inc. (11 trademarks)

10 Maguire Road
Lexington, MA 02421

Entity Type: 03

Trademark Details

Filing Date

February 8, 2021

Registration Date

Not Registered

Published for Opposition

October 19, 2021

Goods & Services

Reagents, nucleic acids, and nucleotides for scientific and research use in the fields of clinical research, drug development, agriculture and genetics research; reagent kits comprised of reagents and chemical preparations for scientific research purposes; samples of nucleotide sequence variants and modified nucleotide sequences for use in the fields of scientific research, clinical research, and scientific diagnostics research

Pharmaceutical preparations for genetic therapies to treat genetically driven disorders in the fields of neurology, gastroenterology, metabolism, immunology, dyslipidaemia, the musculoskeletal system, oncology, and diseases of the retina, liver, heart, lung, bone marrow, brain, muscle, immune system, and kidney; Reagents, nucleic acids, and nucleotides for medical and veterinary purposes; all of the foregoing excluding pharmaceuticals for the treatment of xerostomia

Scientific and laboratory research services in the fields of gene, genome and cellular editing, modification, engineering and regulation for use in developing human and veterinary pharmaceutical and biological preparations; custom design and development of engineered cell lines for others for use in scientific research, and drug discovery and development

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 1, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 1, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 13, 2024 EXRA
SOU EXTENSION 2 GRANTED
Jun 4, 2024 EX2G
SOU EXTENSION 2 FILED
Jun 4, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Jun 4, 2024 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 28, 2024 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 28, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 28, 2024 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 6, 2023 EXRA
SOU EXTENSION 1 GRANTED
Dec 4, 2023 EX1G
SOU EXTENSION 1 FILED
Dec 4, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 4, 2023 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 22, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 22, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 22, 2023 REAP
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 13, 2023 NOAM
TTAB RELEASE CASE TO TRADEMARKS
Apr 28, 2023 TMBN
OPPOSITION TERMINATED NO. 999999
Apr 28, 2023 OP.T
OPPOSITION DISMISSED NO. 999999
Apr 28, 2023 OP.D
OPPOSITION INSTITUTED NO. 999999
Dec 20, 2021 OP.I
EXTENSION OF TIME TO OPPOSE RECEIVED
Nov 17, 2021 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 19, 2021 NPUB
PUBLISHED FOR OPPOSITION
Oct 19, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 29, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 9, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 9, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 9, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 9, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 9, 2021 CNEA
ASSIGNED TO EXAMINER
Sep 1, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 12, 2021 NWOS
NEW APPLICATION ENTERED
Feb 11, 2021 NWAP